Cargando cotizaciones...
Previsión
| Comprar |
1 |
| Mantener |
0 |
| Vender |
0 |
Noticias Ir al feed de noticias
Inspira Technologies wins $596,000 order for AME system from Irish research university
Inspira Technologies has secured a $596,000 order for an AME system (additive manufacturing of electronics) from an Irish technological research university. The company received a non‑refundable 40% advance payment, with the remainder due on delivery. The order includes recurring revenue from consumables, wear parts and annual service fees; delivery, installation and training are planned in the coming weeks and are intended to serve as a reference for further academic and commercial collaborations in Europe. Inspira has a market capitalization of $19.28 million and annual revenue of $290,000. » Más en de.investing.com
Inspira Technologies enters quantum computing and plans to rebrand as QTREX
Inspira Technologies announces a strategic entry into the quantum computing sector and aims to use its additively manufactured AME platform to address 3D connectivity issues in dilution cryostats to improve qubit coherence and system stability. The company, led by CEO Dagi Ben-Noon and COO Avi Shabtay, reports a proof of concept for integrating qubit-relevant components and is negotiating partnerships but provides no details or timelines. Inspira plans to continue its medical technology division as a subsidiary, intends to change its name to QTREX, and points to large market forecasts, but remains financially unprofitable and shows high cash outflows. » Más en de.investing.com
Inspira Technologies terminates two financing agreements
Inspira Technologies announces the written termination of its sales agreement with A.G.P./Alliance Global Partners dated 17 February 2026 and its standby equity purchase agreement with YA II PN, Ltd. dated 12 December 2025. The company has no outstanding obligations under either agreement and no further payments will be made. Inspira cites the goal of a disciplined capital structure as the reason for the move while it prepares for the next strategic phase; the stock has recently fallen sharply and, according to InvestingPro, is fairly valued. » Más en de.investing.com
Datos financieros de la empresa
| (EUR) | jun 2025 | |
|---|---|---|
| Ingresos | 122,6 mil | - |
| Beneficio bruto | 848,42 | - |
| Beneficio neto | -2,71 M | - |
| EBITDA | -3,04 M | - |
Datos fundamentales
| Métrica | Valor |
|---|---|
Capitalización bursátil | 21,83 M € |
Número de acciones | 24,08 M |
Máximo/mínimo de 52 semanas | 1,81 € - 0,29 € |
| Dividendos | No |
Beta | 2,33 |
Ratio P/E | - |
Ratio PEG | - |
Ratio P/B | - |
Ratio P/S | - |
Perfil de la empresa
Inspira Technologies Oxy B.H.N. Ltd. ist ein Unternehmen für medizinische Spezialgeräte, das sich mit der Erforschung, Entwicklung, Herstellung und Vermarktung von Technologien zur Unterstützung der Atmung befasst, die eine Alternative zur invasiven mechanischen Beatmung (MV) bei der Behandlung von Atemversagen darstellen. Sein Hauptprodukt ist das Augmented Respiration Technology System (ART), ein Atemunterstützungssystem mit einer minimalinvasiven, tragbaren Doppellumenkanüle, die in die Jugularvene eingeführt wird und die extrakorporale direkte Blutsauerstoffversorgung zur Erhöhung und Stabilisierung sinkender Sauerstoffsättigungswerte nutzt. Das Unternehmen war früher als Insense Medical Ltd. bekannt und änderte im Juli 2020 seinen Namen in Inspira Technologies Oxy B.H.N. Ltd. Das Unternehmen wurde im Jahr 2018 gegründet und hat seinen Sitz in Ra'annana, Israel.
| Nombre | INSPIRA TECH OXY IS-,125 Aktie |
| CEO | Dagi Shahar Ben-Noon |
| Sede | Ra'anana,
Israel |
| Sitio web | |
| Sector | Consumo discrecional |
| Industria | Bienes duraderos del hogar |
| Salida a bolsa | 14/07/2021 |
| Empleados | 39 |
Símbolos bursátiles
| Bolsa | Símbolo |
|---|---|
NASDAQ | IINN |
Descubrir activos
Los accionistas de INSPIRA TECH OXY IS-,125 Aktie también invierten en los siguientes activos



